Nexentis Technologies Inc.

NXTS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Nov 12, 2024
8-K Oct 2, 2024
8-K Sep 25, 2024
4 Sep 19, 2024
4 Sep 19, 2024
DEF 14A Sep 19, 2024
8-K Sep 12, 2024
PRE 14A Sep 9, 2024
8-K Aug 27, 2024
10-Q Aug 14, 2024
8-K Jul 31, 2024
8-K Jul 9, 2024
8-K Jul 3, 2024
DEF 14A May 31, 2024
PRE 14A May 20, 2024
10-Q May 15, 2024
8-K Apr 16, 2024
10-K Apr 1, 2024
8-K Mar 19, 2024
8-K Feb 21, 2024
8-K Feb 12, 2024
8-K Feb 9, 2024
424B3 Feb 7, 2024
EFFECT Feb 6, 2024
CORRESP Feb 5, 2024
← Newer Page 6 of 13 · 308 filings Older →